Eagle Wealth Strategies’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Buy
3,288
+83
+3% +$7.41K 0.13% 74
2026
Q1
$230K Buy
3,205
+1
+0% +$77 0.1% 96
2025
Q4
$254K Sell
3,204
-394
-11% -$31.1K 0.12% 90
2025
Q3
$271K Buy
3,598
+25
+0.7% +$1.71K 0.14% 84
2025
Q2
$246K Buy
3,573
+17
+0.5% +$1.11K 0.14% 85
2025
Q1
$241K Buy
+3,556
New +$213K 0.15% 79
2024
Q4
Sell
-8,635
Closed -$543K 108
2024
Q3
$543K Buy
8,635
+138
+2% +$8.05K 0.4% 34
2024
Q2
$502K Buy
8,497
+370
+5% +$23.1K 0.41% 34
2024
Q1
$647K Buy
8,127
+596
+8% +$45.5K 0.53% 23
2023
Q4
$595K Buy
+7,531
New +$536K 0.36% 30

Other funds holding CVS

Eagle Wealth Strategies's CVS Position: Q2 2026 in Review

Eagle Wealth Strategies increased its CVS Health (CVS) stake by 2.6% in Q2 2026, buying an estimated $7.41K and bringing the position to 3,288 shares worth $340K. The position accounts for 0.13% of the portfolio, ranked #74.

Eagle Wealth Strategies first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $647K in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Eagle Wealth Strategies held 3,288 shares of CVS Health worth $340K as of Q2 2026.
  • Eagle Wealth Strategies bought 83 CVS Health shares in Q2 2026, an estimated $7.41K.
  • CVS Health made up 0.13% of Eagle Wealth Strategies's portfolio in Q2 2026, its #74 holding.
  • Eagle Wealth Strategies first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Eagle Wealth Strategies's CVS Health position peaked at $647K in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.